Komori
Governance4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

Notice Regarding the Board of Directors’ Opinion on the Shareholder Proposal

The Board of Directors resolved to oppose the proposal submitted by a shareholder for the election of 2 outside directors.

Worth reading
54Recurring
Scored from 1 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
2
People
Wording
Definitive
How definitive the wording is.

Governance structure

Company with Three Statutory Committees
Controlling shareholder
Not disclosed19.75%Voting rights

with respect to major shareholders, Dalton alone held 19.75% of shares and other securities, while the proposing shareholders and their joint holders held 32.84%

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Committee3
Nomination CommitteeRemuneration Committee: not disclosedAudit Committee: not disclosed
Changes this time

The Board of Directors resolved to oppose the shareholder proposal. The Company published its opinion on the proposal to elect 2 directors.

Governance structure
ItemDetails
Corporate Governance StructureCompany with Three Statutory Committees
CommitteeNomination Committee (percentage of outside members: not disclosed), Remuneration Committee: not disclosed, Audit Committee: not disclosed
Controlling shareholderNot disclosed (with respect to major shareholders, Dalton alone held 19.75% of shares and other securities, while the proposing shareholders and their joint holders held 32.84%)
Changes this timeThe Board of Directors resolved to oppose the shareholder proposal. The Company published its opinion on the proposal to elect 2 directors.
Items this document does not state (4)
Number of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company stated that it opposes the proposal because the candidates have close ties to Dalton Group, a major shareholder, raising concerns about their independence; their appointment could give rise to conflicts of interest between general shareholders and Dalton Group; and a Board of Directors comprising the Company’s nominated candidates, including the existing outside directors, would be best positioned to maximize corporate and shareholder value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Board of Directors’ Opinion on the Shareholder Proposal | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori